We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+4.33%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.68B
AUM Growth
-$209M
Cap. Flow
-$341M
Cap. Flow %
-9.26%
Top 10 Hldgs %
13.58%
Holding
1,437
New
112
Increased
524
Reduced
590
Closed
111

Sector Composition

Rank Sector Weight
1 Technology 12.63%
2 Healthcare 11.47%
3 Financials 11.29%
4 Industrials 9.35%
5 Consumer Discretionary 8.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RHT
276
DELISTED
Red Hat Inc
RHT
$3.07M 0.08%
22,876
+105
+0.5% +$16.9K
FV icon
277
First Trust Dorsey Wright Focus 5 ETF
FV
$3.61B
$3.07M 0.08%
104,069
+65,076
+167% +$1.92M
AIG icon
278
American International
AIG
$41.7B
$3.06M 0.08%
57,732
+8,141
+16% +$441K
MPV
279
Barings Participation Investors
MPV
$175M
$3.04M 0.08%
207,144
-3,550
-2% -$52.8K
RY icon
280
Royal Bank of Canada
RY
$291B
$3.04M 0.08%
40,432
+777
+2% +$59.5K
VO icon
281
Vanguard Morningstar Mid-Cap ETF
VO
$106B
$3.04M 0.08%
77,200
+6,836
+10% +$268K
XLI icon
282
State Street Industrial Select Sector SPDR ETF
XLI
$32.8B
$3.03M 0.08%
42,361
-4,389
-9% -$325K
SO icon
283
Southern Company
SO
$109B
$3.03M 0.08%
65,487
-8,625
-12% -$386K
IGV icon
284
iShares Expanded Tech-Software Sector ETF
IGV
$12.7B
$3.03M 0.08%
82,880
+5,930
+8% +$214K
THO icon
285
Thor Industries
THO
$3.9B
$3.01M 0.08%
+30,900
New +$3.15M
FDC
286
DELISTED
First Data Corporation
FDC
$2.93M 0.08%
140,145
-3,893
-3% -$72.1K
IP icon
287
International Paper
IP
$21.6B
$2.93M 0.08%
59,472
-15,562
-21% -$795K
XLV icon
288
State Street Health Care Select Sector SPDR ETF
XLV
$41.9B
$2.93M 0.08%
35,140
-889
-2% -$73.7K
BOTZ icon
289
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.28B
$2.91M 0.08%
132,295
-36,855
-22% -$861K
AEP icon
290
American Electric Power
AEP
$69.6B
$2.9M 0.08%
41,832
-2,370
-5% -$160K
TRV icon
291
Travelers Companies
TRV
$78.1B
$2.9M 0.08%
23,669
+161
+0.7% +$21.1K
HCA icon
292
HCA Healthcare
HCA
$87.2B
$2.89M 0.08%
28,199
+1,234
+5% +$125K
SPB icon
293
Spectrum Brands
SPB
$2.04B
$2.89M 0.08%
35,367
+21,376
+153% +$1.8M
J icon
294
Jacobs Solutions
J
$15.9B
$2.88M 0.08%
54,847
-39,231
-42% -$2.02M
VRNT
295
DELISTED
Verint Systems
VRNT
$2.87M 0.08%
126,888
-1,555
-1% -$33.8K
EWBC icon
296
East-West Bancorp
EWBC
$17.9B
$2.86M 0.08%
43,881
+24
+0.1% +$1.62K
PLNT icon
297
Planet Fitness
PLNT
$4.42B
$2.86M 0.08%
65,000
-65,000
-50% -$2.67M
FUN icon
298
Cedar Fair
FUN
$1.77B
$2.85M 0.08%
45,287
-5,252
-10% -$342K
KMB icon
299
Kimberly-Clark
KMB
$36.3B
$2.85M 0.08%
27,078
-5,431
-17% -$564K
REGN icon
300
Regeneron Pharmaceuticals
REGN
$78.5B
$2.85M 0.08%
8,250
+1,988
+32% +$622K

Similar funds

Oppenheimer & Co's Q2 2018 Portfolio in Review

As of Q2 2018, Oppenheimer & Co held 1,437 positions worth $3.68B, down 5.4% from $3.89B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co withdrew a net $341M in Q2 2018, closing 111 positions and reducing 590 holdings. Its most notable exit was Monsanto Co, an estimated $9.28M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Oppenheimer & Co opened a new position in Thor Industries worth $3.01M.

  • Oppenheimer & Co's largest Q2 2018 buy was Thor Industries: 30,900 shares worth $3.01M.
  • Oppenheimer & Co added most to AT&T in Q2 2018, an estimated $7.02M increase.
  • Oppenheimer & Co's biggest Q2 2018 reduction was Foundation Medicine, Inc., cutting an estimated $63.6M.
  • Oppenheimer & Co fully exited Monsanto Co in Q2 2018, selling an estimated $9.28M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.68B portfolio in Q2 2018.
  • Oppenheimer & Co opened 112 new positions and closed 111 in Q2 2018.
  • Oppenheimer & Co's portfolio value fell 5.4% quarter-over-quarter to $3.68B.

Based on Oppenheimer & Co's 13F filing for Q2 2018, filed 10 Aug 2018.